Should clinical/commercial laboratories maintain the capacity to perform culture tests?
Yes, it is important that clinical and commercials labs be able to detect emerging mutations.
No, public health surveillance should adapt to increasingly popular culture-independent testing methodologies.
Posted 3 years.
See this poll on: